ENTERO · Healthcare · Medical Distribution
Composite scorecard: 35/100 — Quality 30 · Valuation 44 · Momentum 29
| Share price | ₹1,189.70 |
| Market cap | ₹5,270 Cr |
| P/E ratio | 45.9 |
| P/B ratio | 3.1 |
| ROCE | 11.6% |
| Book value | ₹388.26 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹6,591 Cr | ₹146 Cr | 4.0% |
| 2025 | ₹5,096 Cr | ₹107 Cr | 3.0% |
| 2024 | ₹3,922 Cr | ₹40 Cr | 3.0% |
| 2023 | ₹3,300 Cr | ₹-11 Cr | 2.0% |
| 2022 | ₹2,522 Cr | ₹-29 Cr | 1.0% |
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthc